CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -66.7% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -97.1% | 60 | -96.4% | 0.00% | -100.0% |
| Q4 2020 | $102,000 | +13.3% | 1,650 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $90,000 | -42.7% | 1,650 | -90.2% | 0.01% | 0.0% |
| Q2 2019 | $157,000 | -47.7% | 16,917 | -21.7% | 0.01% | -50.0% |
| Q1 2019 | $300,000 | +20.0% | 21,617 | -5.6% | 0.01% | +11.1% |
| Q4 2018 | $250,000 | -25.1% | 22,897 | -13.4% | 0.01% | 0.0% |
| Q3 2018 | $334,000 | -4.0% | 26,447 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $348,000 | -3.3% | 26,447 | 0.0% | 0.01% | -16.7% |
| Q1 2018 | $360,000 | +120.9% | 26,447 | -3.4% | 0.01% | +140.0% |
| Q4 2017 | $163,000 | -19.7% | 27,370 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $203,000 | -26.2% | 27,370 | -6.8% | 0.01% | -12.5% |
| Q2 2017 | $275,000 | -11.6% | 29,370 | -31.3% | 0.01% | -11.1% |
| Q1 2017 | $311,000 | -1.6% | 42,750 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $316,000 | – | 42,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |